Goldman Sachs Removes JNJ from US Conviction List Amid Valuation Concerns

Goldman Sachs has removed Johnson & Johnson (JNJ) from its US Conviction List, although it still maintains a Buy rating on the stock. The decision signals a strategic reassessment by the firm but underscores continued confidence in JNJ's long-term prospects.

JNJ offers a dividend yield of 2.04% with a conservative payout ratio of 50% and a steady 3-year dividend growth rate of 4.9%, supporting a thesis of sustainable income despite being significantly overvalued.

The company's financial health is strong, particularly in profitability and financial strength, suggesting solid operational performance amid valuation concerns.